Solid biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Charlestown, mass., may 02, 2024 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 38,508 restricted stock units (“rsus”) to two newly hired employees.

SLDB Ratings Summary

SLDB Quant Ranking